Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD
Clinical trial NCT06011577 · TERMINATED
Trial details
- NCT number
- NCT06011577
- Sponsor
- Levomecor Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-17
- Primary completion
- 2024-12-19
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.